2019 International Congress » Quality of Life

Date: Monday, September 23, 2019

Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Meeting: 2019 International Congress

1:45pm-3:15pm: “So much easier”; patient’s perceptions of Virtual Clinics for Parkinson’s Disease

L. Evans, B. Mohamed, EC. Thomas (Cardiff, United Kingdom)

1:45pm-3:15pm: A Smart Device System (Wearable technology band) to Identify New Phenotypical Characteristics in Parkinson‘s disease patients

V. Sharma, S. Sharma (Delhi, India)

1:45pm-3:15pm: Advanced Care Planning in complex Parkinson’s disease

L. Richardson, N. Butt, M. Khwaja, H. Avery, G. Alg, A. Chatterjee (Reading, United Kingdom)

1:45pm-3:15pm: An Experimental Study to Assess the Professional and Social Consequences of Tardive Dyskinesia

R. Ayyagari, D. Goldschmidt, F. Mu, S. Caroff, B. Carroll (Boston, MA, USA)

1:45pm-3:15pm: Association between Gait during Daily Life and Clinical Measures: Effects of Bout Length

V. Shah, J. Mcnames, C. Curtze, M. Mancini, P. Carlson-Kuhta, J. Nutt, M. El Gohary, F. Horak (Portland, OR, USA)

1:45pm-3:15pm: Beliefs, Knowledge and Attitudes Towards Parkinson’s Disease: Turkey Experience from a Global Perspective

Y. Degirmenci, P. Limousin, GM. Hariz, N. Cakar (Duzce, Turkey)

1:45pm-3:15pm: Changes in close relationships among patients with Parkinson’s disease and their partners following initiation of device-aided treatment

J. Timpka, M. Scharfenort, T. Sahlström, V. Hernström, T. Henriksen, D. Nyholm, P. Odin (Lund, Sweden)

1:45pm-3:15pm: Complex disease burden in Parkinson’s and Advance Care Planning

M. Khwaja, A. Chatterjee, G. Alg, A. Cotton, L. Richardson, H. Avery (Reading, United Kingdom)

1:45pm-3:15pm: Considerations before initiating therapy in Parkinsonism: basing on the health-related quality of life.

FT. Liu, J. Wang (Shanghai, China)

1:45pm-3:15pm: Correlation between degree of dysarthria, motor severity and quality of life in patients with Parkinson’s disease

M. Olchik, C. Rieder, L. Scudeiro, R. Rech, R. Millette, A. Ayres (Porto Alegre, Brazil)

1:45pm-3:15pm: Correlation Between Drooling and Quality of Life in Parkinson’s Disease

O. Criciotoiu, D. Stanca, R. Latea, L. Giurgiulescu, A. Mita, V. Gheorman, D. Gheonea (Craiova, Romania)

1:45pm-3:15pm: Daytime sleepiness in Parkinson’s disease: an indicator of impaired activities of daily living

T. Canento, J. Tan, B. Cruse, C. Wools, M. Ghaly, M. Beckley, F. Leen, AH. Evans (Melbourne, Australia)

1:45pm-3:15pm: Difference in perception of the wearing-off between patients and physicians in Parkinson’s disease

Y. Tsuboi, R. Nakagawa, M. Ishido, Y. Yoshinaga, T. Hashimoto, T. Mishima, S. Fujioka (Fukuoka, Japan)

1:45pm-3:15pm: Does socio-economic status have impact on quality of life in persons with Parkinson’s disease?

R. Aggarwal, V. Goyal, A. Srivastava, M. Behari (Delhi, India)

1:45pm-3:15pm: Dyadic analysis of the Parkinson’s disease impact on the patient-spouse couple

E. Constant, E. Brugallé, E. Wawrziczny, B. Flinois, K. Dujardin, P. Antoine (Villeneuve D'Ascq, France)

1:45pm-3:15pm: Identifying the association of depression and distress in Pakistani patients diagnosed with Parkinsonism syndrome

A. Fatima (Lahore, Pakistan)

1:45pm-3:15pm: Impact of cathine and carthinone use among Parkinson’s disease Patients

S. Zewde (Addis Ababa, Ethiopia)

1:45pm-3:15pm: Impact of cathine and cathinone use among Parkinson’s disease Patients

S. Zewde (Addis Ababa, Ethiopia)

1:45pm-3:15pm: Longitudinal digital observation of the holistic quality of the life of patients with Parkinson’s disease

F. Thieken, A. Greuel, L. Timmermann, K. Sohrabi, C. Woopen, B. Schmitz-Luhn, A. Janhsen, C. Eggers (Marburg, Germany)

1:45pm-3:15pm: Motor and non-motor symptoms burden, autonomy, quality of life and principal caregiver status is worse in patients with 5-2-1 positive criteria: a simple screening tool for identifying PD patients who need an optimization of Parkinson´s treatment.

D. Santos, T. de Deus, E. Suárez Castro, A. Aneiros (A Coruña, Spain)

1:45pm-3:15pm: Parkinson’s Disease Treatments and Outcomes: US v Non-US Patients

TL. Davis, M. Rafferty, K. Lyons, A. Ramirez-Zamora, H. Gao, S. Wu, F. Cubilllos, EC. Nelson (Lebanon, NH, USA)

1:45pm-3:15pm: Patient insights into the burden of OFF-episodes in Parkinson’s disease: Qualitative Interviews

C. Ervin, J. Sutphin, A. Thach, A. Lee, C. Mansfield, J. Coulter (Research Triangle Park, NC, USA)

1:45pm-3:15pm: People with Parkinson’s Disease (PPD): disease, stigma and the others

M. Bacigalupe (La Plata, Argentina)

1:45pm-3:15pm: Pre-Dopa DBS: is early deep brain stimulation able to modify the natural course of Parkinson’s disease?

M. Porta, D. Servello, AR. Bona, E. Zekaj, G. Gonzalez-Escamilla, G. Groppa (Milan, Italy)

1:45pm-3:15pm: Predictors of Health-Related Quality of Life in Patients with Cervical Dystonia

SA. Reijneveld, Z. Gdovinova, MAJ. Tijssen, JP. van Dijk, T. Hoekstra, M. Turcanova Koprusakova, M. Smit, M. Skorvanek, V. Han (Martin, Slovakia)

1:45pm-3:15pm: Quality of Life Indicators and Psycho-Social Adaptation of Patients with Essential Tremor

A. Taskinbayeva (Almaty, Kazakhstan)

1:45pm-3:15pm: Safinamide in the treatment of URINARY symptoms in PARKinson’s disease (SURINPARK)

A. Gómez López, I. Pareés Moreno, S. Fanjul Arbós, JL. López Sendon, JC. Martínez Castrillo, A. Alonso Cánovas (Madrid, Spain)

1:45pm-3:15pm: Sleep-related quality of life predictors in Parkinson’s disease

D. Martínez-Roque, S. Castillo-Torres, C. Cerda-Contreras, I. Estrada-Bellmann, B. Chávez-Luévanos (Monterrey, Mexico)

1:45pm-3:15pm: Social work support is associated with better health-related quality of life in late stage Parkinson’s disease

P. Gonzalez-Latapi, M. Rafferty, S. Wu, H. Chen, T. Simuni (Chicago, IL, USA)

1:45pm-3:15pm: Stigma and Quality of life in Parkinson’s disease patients on different treatment regimens

O. Vanta, L. Perju-Dumbrava, L. Perju-Dumbrava (Cluj-Napoca, Romania)

1:45pm-3:15pm: Stigma in Egyptian patients with Parkinson’s disease

M. Salim, A. Helmy, A. Shalash, E. Abdel Dayem (Cairo, Egypt)

1:45pm-3:15pm: Stimulation challenge test after STN DBS improves postoperative satisfaction in patients with Parkinson’s Disease

V. Geraedts, J. van Hilten, J. Marinus, A. Mosch, K. Naarding, C. Hoffmann, N. Vd Gaag, MF. Contarino (Leiden, Netherlands)

1:45pm-3:15pm: The impact of clinical care coordination on patient quality of life in the Atypical Parkinsonism clinic

M. Harris, J. Donnelly, L. Massey, B. Ghosh (Southampton, United Kingdom)

1:45pm-3:15pm: The Impact of Parkinson’s Disease to Quality of Life

R. Pinzon, RDL. Sanyasi (Yogyakarta, Indonesia)

1:45pm-3:15pm: The influence of relationship quality on health-related quality of life when coping with Parkinson’s disease: a mediation analysis

M. Karlstedt, SM. Fereshtehnejad, D. Aarsland, J. Lökk (Huddinge, Sweden)

1:45pm-3:15pm: The Preferences of Patients with Parkinson’s Disease and their Family Members for Place of End-of-Life Care

R. Kozáková, R. Bužgová, M. Bar, M. škutová, P. Ressner, P. Bártová (Ostrava, Czech Republic)

1:45pm-3:15pm: Understanding the Needs and Concerns of Newly Diagnosed People with Parkinson’s Disease

V. Todaro, M. Feeney, A. Diaz, S. Rosenfeld, J. Gannon (New York, NY, USA)

1:45pm-3:15pm: What patients need – a qualitative analysis of consultations prior to deep brain stimulation in patients with Parkinson’s disease

R. Dano, JN. Petry-Schmelzer, J. Steffen, G. Fink, M. Barbe (Cologne, Germany)

« View all sessions from the 2019 International Congress.